NCT07105982View on ClinicalTrials.gov

Radiolabeled TSPO Targeted Molecular Probe in AMI

Not yet recruitingOBSERVATIONAL

Enrollment

8

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Acute Myocardial Infarction (AMI)

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT07105982 - Radiolabeled TSPO Targeted Molecular Probe in AMI | Biotech Hunter | Biotech Hunter